Product Catalog

TirzepatideSpecifications & Batch COA

Dual GIP/GLP-1 receptor agonist. Superior weight loss efficacy with improved glycemic control in clinical trials.

KERUIHK-0102Tirzepatide product vial
Lyophilized PowderProduct image
Weight Loss & Metabolic

Tirzepatide

GMPKERUIHK-0102

Dual GIP/GLP-1 receptor agonist. Superior weight loss efficacy with improved glycemic control in clinical trials.

Product Specifications

CAS Number
2023788-19-2
Catalog Purity
≥99.47%
Form
Lyophilized Powder
Catalog Grade
GMP
View batch documentation

Product Details

Tirzepatide specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
Tirzepatide
Catalog reference
KERUIHK-0102
CAS number
2023788-19-2
Category
Weight Loss & Metabolic
Physical form
Lyophilized Powder

Latest reported batch: Tirzepatide

Batch PB-2026-TIR-0849 · Oct 3, 2026

Reported appearance
White lyophilized powder
Reported molecular weight / identity
4813.26 Da
Analytical method
RP-HPLC / MALDI-TOF

Reported analytical results

HPLC Purity
99.19%Report specification: ≥98.0%
Molecular Weight (MS)
4813.26 DaReport specification: 4813.47 ± 0.5 Da
Amino Acid Analysis
ConformsReport specification: Conforms to sequence
Endotoxin (LAL)
0.26 EU/mgReport specification: < 1.0 EU/mg
Show 5 more test results
Sterility (USP <71>)
No growth observedReport specification: No evidence of microbial growth
Residual Solvents
< ICH Q3C limitsReport specification: ICH Q3C Class 2
Optical Rotation
-32.7 °Report specification: -30° to -35°
Water Content (KF)
6.02%Report specification: ≤ 8.0%
Peptide Content (AAA)
95.87%Report specification: ≥95.0%
Source COA: PB-2026-TIR-0849-R20261003
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-TIR-0849Report product: TirzepatideOct 3, 2026 · Reported purity: 99.19%View this batch COA
PB-2026-TIR-0849Report product: TirzepatideAug 27, 2026 · Reported purity: 99.3%View this batch COA
PB-2026-TIR-0425Report product: TirzepatideJul 28, 2026 · Reported purity: 99.1%View this batch COA
Show 4 earlier reports
PB-2026-TIR-0198Report product: TirzepatideMar 31, 2026 · Reported purity: 99.1%View this batch COA
PB-2025-TIR-0154Report product: TirzepatideNov 20, 2025 · Reported purity: 99.0%View this batch COA
PB-2025-TIR-0089Report product: TirzepatideJul 08, 2025 · Reported purity: 99.1%View this batch COA
PB-2025-TIR-0033Report product: TirzepatideApr 22, 2025 · Reported purity: 99.2%View this batch COA

Product Inquiry

Request a Tirzepatide quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products